Nafamostat mesylate-induced hyperkalemia in critically ill patients with COVID-19: Four case reports
Sign Up to like & getrecommendations! Published in 2020 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v8.i21.5320
Abstract: BACKGROUND Nafamostat mesylate (NM) may prove to be one of the key drugs effective against coronavirus disease 2019 (COVID-19) because of its anti-viral properties and the potential to manage coagulopathy. However, NM tends to increase… read more here.
Keywords: case; nafamostat mesylate; mesylate induced; induced hyperkalemia ... See more keywords